We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
Cap. Flow
+$2.46B
Cap. Flow %
60.1%
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$37.8M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$35.1M
3
TMUS icon
T-Mobile US
TMUS
+$30.4M
4
NU icon
Nu Holdings
NU
+$27.8M
5
ED icon
Consolidated Edison
ED
+$26.1M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$17M
2
MRVL icon
Marvell Technology
MRVL
+$16.2M
3
NVO
Novo Nordisk
NVO
+$16.1M
4
NOW icon
ServiceNow
NOW
+$13.3M
5
WMT icon
Walmart Inc
WMT
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 15.87%
2 Industrials 14.69%
3 Financials 14.36%
4 Healthcare 12.68%
5 Consumer Discretionary 12.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GCMG icon
851
GCM Grosvenor
GCMG
$737M
$1.2M 0.03%
+103,995
New +$1.29M
GPOR icon
852
Gulfport Energy Corp
GPOR
$2.82B
$1.19M 0.03%
+5,937
New +$1.11M
SKYW icon
853
Skywest
SKYW
$4.35B
$1.19M 0.03%
+11,591
New +$1.1M
NABL icon
854
N-able
NABL
$844M
$1.19M 0.03%
147,130
+103,767
+239% +$775K
HOOD icon
855
Robinhood
HOOD
$80.7B
$1.19M 0.03%
12,708
+4,870
+62% +$288K
CLDX icon
856
Celldex Therapeutics
CLDX
$2.94B
$1.19M 0.03%
+58,398
New +$1.14M
DYN icon
857
Dyne Therapeutics
DYN
$4.68B
$1.19M 0.03%
124,628
+43,963
+55% +$484K
MEDP icon
858
Medpace
MEDP
$16.3B
$1.18M 0.03%
+3,762
New +$1.13M
HAFC icon
859
Hanmi Financial
HAFC
$935M
$1.18M 0.03%
+47,830
New +$1.09M
AVY icon
860
Avery Dennison
AVY
$12.8B
$1.18M 0.03%
+6,725
New +$1.18M
NMRK icon
861
Newmark Group
NMRK
$2.64B
$1.18M 0.03%
97,048
+72,096
+289% +$806K
TRST
862
Trustco Bank Corp NY
TRST
$953M
$1.18M 0.03%
+35,173
New +$1.08M
DHIL
863
DELISTED
Diamond Hill
DHIL
$1.17M 0.03%
+8,062
New +$1.11M
CHDN icon
864
Churchill Downs
CHDN
$6.17B
$1.17M 0.03%
+11,589
New +$1.13M
MGRC icon
865
McGrath RentCorp
MGRC
$2.87B
$1.17M 0.03%
10,089
+4,890
+94% +$543K
UL icon
866
Unilever
UL
$142B
$1.17M 0.03%
+16,934
New +$1.19M
DAR icon
867
Darling Ingredients
DAR
$9.32B
$1.16M 0.03%
+30,686
New +$1.01M
POWL icon
868
Powell Industries
POWL
$6.79B
$1.16M 0.03%
+16,539
New +$998K
MAS icon
869
Masco
MAS
$14.3B
$1.16M 0.03%
17,993
-789
-4% -$49.7K
LMND icon
870
Lemonade
LMND
$3.66B
$1.15M 0.03%
+26,360
New +$878K
AVNT icon
871
Avient
AVNT
$3.29B
$1.15M 0.03%
+35,535
New +$1.23M
NMIH icon
872
NMI Holdings
NMIH
$3.37B
$1.15M 0.03%
27,142
+9,079
+50% +$341K
PB icon
873
Prosperity Bancshares
PB
$8.9B
$1.14M 0.03%
16,273
-10,241
-39% -$705K
SHG icon
874
Shinhan Financial Group
SHG
$32.1B
$1.14M 0.03%
+25,197
New +$960K
RY icon
875
Royal Bank of Canada
RY
$287B
$1.13M 0.03%
+8,595
New +$1.05M
33 34
35
36 37

Similar funds

HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.02B AUM 21.87% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return

Y-Intercept (HK)'s Q2 2025 Portfolio in Review

As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.

  • Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
  • Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
  • Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
  • Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
  • Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
  • Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
  • Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.

Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.